TNFRSF21 and melanoma: Treatment with LPA alone resulted in a marked downregulation of HLA-DR in both A375 (Fig. 5a) and A2058 melanoma cells (Fig. 5c), which was lost after pharmacological inhibition of LPAR1 by AM095 or siDR6-mediated silencing of DR6 expression.